Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Shaw

Showing results (291-300 of 319) with videos related to

Pageof 32
Sort By:
Health Science Reports|August 24, 2022
Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohortSofia R Bartlett, Andrey Verich, Joanne Carson, et al.
Antiviral Research|May 18, 2010
Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-d-2'-ethynyl-7-deaza-adenosine triphosphateDerek R Latour, Andreas Jekle, Hassan Javanbakht, et al.
Pediatric Rheumatology Online Journal|September 2, 2025
A roadmap for navigating child health research data sharing across Canada and beyond - building on UCAN CAN-DUBrittany Gerber, Gillian R Currie, Alexander Mosoiu, et al.
European Journal of Gastroenterology & Hepatology|January 3, 2020
Cost effectiveness of treatment models of care for hepatitis C: the South Australian state-wide experienceJeyamani Ramachandran, Billingsley Kaambwa, Kate Muller, et al.
The New England Journal of Medicine|August 2, 2023
Selective Inhibition of Na<sub>V</sub>1.8 with VX-548 for Acute PainJim Jones, Darin J Correll, Sandra M Lechner, et al.
Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.
Frontiers in Veterinary Science|April 2, 2020
Molecular Characterization of <i>Haemaphysalis</i> Species and a Molecular Genetic Key for the Identification of <i>Haemaphysalis</i> of North AmericaAlec T Thompson, Kristen Dominguez, Christopher A Cleveland, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failureFred Poordad, Stanislas Pol, Armen Asatryan, et al.
International Journal of Toxicology|June 3, 2022
Increasing the Reuse of Protein Non-Naïve Nonhuman Primates in Pharmaceutical Drug Discovery and Development: An Overview and Industry Position on the Challenges and BenefitsCharles Mattis, Natalie Bratcher, Monika Burns, et al.
Communications Chemistry|January 25, 2023
Spatial and temporal scales of variability for indoor air constituentsPascale S J Lakey, Youngbo Won, David Shaw, et al.
Pageof 32

Showing results (291-300 of 319) with videos related to

Sort By:
Pageof 32
Health Science Reports|August 24, 2022
Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohortSofia R Bartlett, Andrey Verich, Joanne Carson, et al.
Antiviral Research|May 18, 2010
Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-d-2'-ethynyl-7-deaza-adenosine triphosphateDerek R Latour, Andreas Jekle, Hassan Javanbakht, et al.
Pediatric Rheumatology Online Journal|September 2, 2025
A roadmap for navigating child health research data sharing across Canada and beyond - building on UCAN CAN-DUBrittany Gerber, Gillian R Currie, Alexander Mosoiu, et al.
European Journal of Gastroenterology & Hepatology|January 3, 2020
Cost effectiveness of treatment models of care for hepatitis C: the South Australian state-wide experienceJeyamani Ramachandran, Billingsley Kaambwa, Kate Muller, et al.
The New England Journal of Medicine|August 2, 2023
Selective Inhibition of Na<sub>V</sub>1.8 with VX-548 for Acute PainJim Jones, Darin J Correll, Sandra M Lechner, et al.
Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.
Frontiers in Veterinary Science|April 2, 2020
Molecular Characterization of <i>Haemaphysalis</i> Species and a Molecular Genetic Key for the Identification of <i>Haemaphysalis</i> of North AmericaAlec T Thompson, Kristen Dominguez, Christopher A Cleveland, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failureFred Poordad, Stanislas Pol, Armen Asatryan, et al.
International Journal of Toxicology|June 3, 2022
Increasing the Reuse of Protein Non-Naïve Nonhuman Primates in Pharmaceutical Drug Discovery and Development: An Overview and Industry Position on the Challenges and BenefitsCharles Mattis, Natalie Bratcher, Monika Burns, et al.
Communications Chemistry|January 25, 2023
Spatial and temporal scales of variability for indoor air constituentsPascale S J Lakey, Youngbo Won, David Shaw, et al.
Pageof 32